NICE grants restricted access to new era of rheumatoid arthritis treatment ... - PharmiWeb.com (press release)

NICE grants restricted access to new era of rheumatoid arthritis treatment ... PharmiWeb.com (press release) In rheumatoid arthritis, IL-6 causes synovitis, joint destruction, and many systemic manifestations such as fatigue, anaemia and osteoporosis ; blocking ... and more »

Experimental nonsteroidal treatment of asthma shows promise - PharmaLive.com (press release)

Experimental nonsteroidal treatment of asthma shows promise PharmaLive.com (press release) ... not only for asthma but also other inflammatory diseases that NF-κB plays a role in, such as atherosclerosis and rheumatoid arthritis," Oh said. ... and more »

Companies in the Biotech industry to watch: PWRM, TTHI, CELG - TMCnet

Companies in the Biotech industry to watch: PWRM, TTHI, CELG TMCnet ... TT-301 in a Phase 1 clinical study. TT-301 is a small molecule compound that has demonstrated efficacy in preclinical models of rheumatoid arthritis, ...

Experimental non-steroidal treatment of asthma holds promise - Daily News & Analysis

Experimental non-steroidal treatment of asthma holds promise Daily News & Analysis ... Richmond, Virginia, found said that the find may help treat other inflammatory diseases such as atherosclerosis and rheumatoid arthritis too. ... and more »